WSJ Your Money Briefing What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure
17 snips
Sep 27, 2025 CarMax's disappointing earnings have left investors rattled, highlighting struggles in the used-car market. Meanwhile, Intel’s stock has surged a remarkable 46% this month, driven by promising partnership talks and strategic investments. In another twist, Kenvue is facing legal challenges related to Tylenol, leading to a notable decline in its shares. Tune in as the host dissects these market movements and uncovers what’s influencing the economy this week.
AI Snips
Chapters
Transcript
Episode notes
AI-Powered Economy Vs. Market Skepticism
- Strong economic data this week reinforced the view of an AI-powered recovery in the U.S. economy.
- Yet markets cooled late in the week as high valuations and consumer stress raised skepticism.
Intel's Rapid Comeback
- Intel's stock surged after reports of partnerships and an NVIDIA investment bolstered momentum.
- The stock nearly doubled from July lows and rose 46% this month on renewed investor confidence.
CarMax Earnings Shock
- CarMax reported weak quarterly results driven by a sharp second-quarter drop in used-car sales.
- The company said consumers have been "distressed for a little while," and shares plunged to a five-year low.